Search

everythinglearnresearchcommunity

for

Search:↓

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might decrease the risk. AST also lessens the chance of cancer coming back but doesn't really affect survival rates. More research is needed to understand AST's benefits for different bladder cancers.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

Understanding hair health and disorders is important for effective treatment.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

5ARI treatment improves PSA test accuracy for prostate cancer diagnosis.

Finasteride effectively slowed hair loss and promoted hair growth in Taiwanese men.

Finasteride effectively slowed hair loss and promoted hair growth in Taiwanese men with AGA.

Correct testosterone levels for age to treat prostate cancer, using low dose treatments as necessary.

The compound 4c showed strong potential as an anticancer agent.

Testosterone works in different ways, including direct interaction with its receptor, conversion to other hormones for specific effects on genitalia, hair, bones, and muscle, and changes in body fat and sexual function when low.

There's no link between hair loss type androgenic alopecia and benign prostatic hyperplasia, but early hair loss and family history can mean more severe alopecia.

Methylated gene parts may cause finasteride-resistance in some enlarged prostate patients.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

The saw palmetto extract effectively inhibits an enzyme linked to prostate issues, showing promise for prostate health.

Energy healing treatment improved flutamide's solubility and stability, potentially enhancing its effectiveness for prostate cancer.

Serenoa repens is not proven effective for hair loss and may delay prostate cancer detection.

Swedish men with the E213 A-allele of the androgen receptor have a lower risk of prostate cancer.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Men with less sun-sensitive skin have lower PSA levels, while men with more sun-sensitive skin have higher PSA levels.

Baldness, especially at the front, may lower the risk of testicular cancer by 31%, but its link to prostate cancer is unclear.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.

Oral finasteride works better than topical minoxidil for hair growth, both are safe.

Antiandrogen drugs can reduce PSA levels in women with excess hair, suggesting PSA is a sign of male hormone activity in women.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Dutasteride may lower the chance of finding prostate cancer in men with enlarged prostates.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

Men with male pattern baldness have a higher risk of dying from prostate cancer.